{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:23:21Z","timestamp":1792193001106,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40119-021-00251-5","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T18:02:27Z","timestamp":1642356147000},"page":"33-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pulmonary Hypertension in the Population with Down Syndrome"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-502X","authenticated-orcid":false,"given":"Douglas S.","family":"Bush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Dunbar","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"key":"251_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ppul.23633","volume":"52","author":"E Naumburg","year":"2017","unstructured":"Naumburg E, Soderstrom L, Huber D, Axelsson I. Risk factors for pulmonary arterial hypertension in children and young adults. Pediatr Pulmonol. 2017;52:636\u201341.","journal-title":"Pediatr Pulmonol"},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2018.06.031","volume":"202","author":"D Bush","year":"2018","unstructured":"Bush D, Galambos C, Ivy DD, Abman SH, Wolter-Warmerdam K, Hickey F. Clinical characteristics and risk factors for developing pulmonary hypertension in children with Down syndrome. J Pediatr. 2018;202:212\u20139.","journal-title":"J Pediatr"},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4250\/jcu.2015.23.2.72","volume":"23","author":"N Espinola-Zavaleta","year":"2015","unstructured":"Espinola-Zavaleta N, Soto ME, Romero-Gonzalez A, Gomez-Puente Ldel C, Munoz-Castellanos L, Gopal AS, et al. Prevalence of congenital heart disease and pulmonary hypertension in Down\u2019s syndrome: an echocardiographic study. J Cardiovasc Ultrasound. 2015;23:72\u20137.","journal-title":"J Cardiovasc Ultrasound"},{"key":"251_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","volume":"169","author":"ME Weijerman","year":"2010","unstructured":"Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr. 2010;169:1195\u20139.","journal-title":"Eur J Pediatr"},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0002-9149(69)90428-7","volume":"24","author":"L Cullum","year":"1969","unstructured":"Cullum L, Liebman J. The association of congenital heart disease with Down\u2019s syndrome (mongolism). Am J Cardiol. 1969;24:354\u20137.","journal-title":"Am J Cardiol"},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/GIM.0b013e3181634867","volume":"10","author":"SB Freeman","year":"2008","unstructured":"Freeman SB, Bean LH, Allen EG, Tinker SW, Locke AE, Druschel C, et al. Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genetics Med. 2008;10:173\u201380.","journal-title":"Genetics Med"},{"key":"251_CR7","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","volume":"132","author":"SH Abman","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037\u201399.","journal-title":"Circulation"},{"key":"251_CR8","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.athoracsur.2015.11.047","volume":"101","author":"JL Colquitt","year":"2016","unstructured":"Colquitt JL, Morris SA, Denfield SW, Fraser CD, Wang Y, Kyle WB. Survival in children with Down syndrome undergoing single-ventricle palliation. Ann Thorac Surg. 2016;101:1834\u201341.","journal-title":"Ann Thorac Surg"},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/jar.12446","volume":"31","author":"L O'Leary","year":"2018","unstructured":"O\u2019Leary L, Hughes-McCormack L, Dunn K, Cooper SA. Early death and causes of death of people with Down syndrome: a systematic review. J Appl Res Intellect Disabil. 2018;31:687\u2013708.","journal-title":"J Appl Res Intellect Disabil"},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","volume":"359","author":"Q Yang","year":"2002","unstructured":"Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down\u2019s syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002;359:1019\u201325.","journal-title":"Lancet"},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00246-006-0011-6","volume":"28","author":"CL Cua","year":"2007","unstructured":"Cua CL, Blankenship A, North AL, Hayes J, Nelin LD. Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol. 2007;28:250\u20134.","journal-title":"Pediatr Cardiol"},{"key":"251_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1590\/0103-0582201432218913","volume":"32","author":"FA Mourato","year":"2014","unstructured":"Mourato FA, Villachan LR, Mattos SS. Prevalence and profile of congenital heart disease and pulmonary hypertension in Down syndrome in a pediatric cardiology service. Rev Paul Pediatr. 2014;32:159\u201363.","journal-title":"Rev Paul Pediatr"},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","volume":"53","author":"EB Rosenzweig","year":"2018","unstructured":"Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2018;53:1801916.","journal-title":"Eur Respir J"},{"key":"251_CR14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0300-8932(03)76978-4","volume":"56","author":"FJ de Rubens","year":"2003","unstructured":"de Rubens FJ, del Pozzo MB, Pablos Hach JL, Calderon Jimenez C. Castrejon Urbina R [Heart malformations in children with Down syndrome]. Rev Esp Cardiol. 2003;56:894\u20139.","journal-title":"Rev Esp Cardiol"},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1161\/CIRCGENETICS.111.960872","volume":"5","author":"H Li","year":"2012","unstructured":"Li H, Cherry S, Klinedinst D, DeLeon V, Redig J, Reshey B, et al. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circ Cardiovasc Genet. 2012;5:301\u20138.","journal-title":"Circ Cardiovasc Genet"},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00246-018-1951-3","volume":"39","author":"KM Alharbi","year":"2018","unstructured":"Alharbi KM, Al-Mazroea AH, Abdallah AM, Almohammadi Y, Carlus SJ, Basit S. Targeted next-generation sequencing of 406 genes identified genetic defects underlying congenital heart disease in Down syndrome patients. Pediatr Cardiol. 2018;39:1676\u201380.","journal-title":"Pediatr Cardiol"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","volume":"120","author":"MG Duffels","year":"2007","unstructured":"Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198\u2013204.","journal-title":"Int J Cardiol"},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1542\/peds.58.6.893","volume":"58","author":"RD Greenwood","year":"1976","unstructured":"Greenwood RD, Nadas AS. The clinical course of cardiac disease in Down\u2019s syndrome. Pediatrics. 1976;58:893\u20137.","journal-title":"Pediatrics"},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1378\/chest.09-2861","volume":"137","author":"I Adatia","year":"2010","unstructured":"Adatia I, Kothari SS, Feinstein JA. Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective. Chest. 2010;137:52S-61S.","journal-title":"Chest"},{"key":"251_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1056\/NEJM198211043071902","volume":"307","author":"TP Cooney","year":"1982","unstructured":"Cooney TP, Thurlbeck WM. Pulmonary hypoplasia in Down\u2019s syndrome. N Engl J Med. 1982;307:1170\u20133.","journal-title":"N Engl J Med"},{"key":"251_CR21","first-page":"919","volume":"22","author":"L Betsy","year":"1990","unstructured":"Betsy L, Schloo M, Gordon F, Vawter M, Lynn M, Reid M. Down syndrome: patterns of disturbed lung growth. Human Pathol. 1990;22:919\u201323.","journal-title":"Human Pathol"},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpeds.2016.08.063","volume":"180","author":"D Bush","year":"2017","unstructured":"Bush D, Abman SH, Galambos C. Prominent intrapulmonary bronchopulmonary anastomoses and abnormal lung development in infants and children with Down syndrome. J Pediatr. 2017;180:156-62e1.","journal-title":"J Pediatr"},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"0159005","DOI":"10.1371\/journal.pone.0159005","volume":"11","author":"C Galambos","year":"2016","unstructured":"Galambos C, Minic AD, Bush D, Nguyen D, Dodson B, Seedorf G, et al. Increased lung expression of anti-angiogenic factors in Down syndrome: potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS ONE. 2016;11:0159005.","journal-title":"PLoS ONE"},{"key":"251_CR24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1460-9592.2007.02296.x","volume":"17","author":"K Kageyama","year":"2007","unstructured":"Kageyama K, Hashimoto S, Nakajima Y, Shime N, Hashimoto S. The change of plasma endothelin-1 levels before and after surgery with or without Down syndrome. Paediatr Anaesth. 2007;17:1071\u20137.","journal-title":"Paediatr Anaesth"},{"key":"251_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11748-017-0809-6","volume":"66","author":"M Aoki","year":"2018","unstructured":"Aoki M, Hirono K, Higuma T, Suzuki Y, Nakayama K, Yamashita A, et al. Pulmonary vascular disease in a failed Fontan patient with Down\u2019s syndrome. Gen Thorac Cardiovasc Surg. 2018;66:299\u2013302.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"251_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.amjcard.2004.04.047","volume":"94","author":"M Cappelli-Bigazzi","year":"2004","unstructured":"Cappelli-Bigazzi M, Santoro G, Battaglia C, Palladino MT, Carrozza M, Russo MG, et al. Endothelial cell function in patients with Down\u2019s syndrome. Am J Cardiol. 2004;94:392\u20135.","journal-title":"Am J Cardiol"},{"key":"251_CR27","doi-asserted-by":"crossref","unstructured":"Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016;5.","DOI":"10.7554\/eLife.16220"},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.1600108","volume":"199","author":"JJ Buie","year":"2017","unstructured":"Buie JJ, Renaud LL, Muise-Helmericks R, Oates JC. IFN-alpha negatively regulates the expression of endothelial nitric oxide synthase and nitric oxide production: implications for systemic lupus erythematosus. J Immunol. 2017;199:1979\u201388.","journal-title":"J Immunol"},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","volume":"114","author":"PM George","year":"2014","unstructured":"George PM, Oliver E, Dorfmuller P, Dubois OD, Reed DM, Kirkby NS, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res. 2014;114:677\u201388.","journal-title":"Circ Res"},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40248-016-0082-z","volume":"12","author":"R Papani","year":"2017","unstructured":"Papani R, Duarte AG, Lin YL, Kuo YF, Sharma G. Pulmonary arterial hypertension associated with interferon therapy: a population-based study. Multidiscip Respir Med. 2017;12:1.","journal-title":"Multidiscip Respir Med"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymgme.2018.09.004","volume":"125","author":"LA Adang","year":"2018","unstructured":"Adang LA, Frank DB, Gilani A, Takanohashi A, Ulrick N, Collins A, et al. Aicardi goutieres syndrome is associated with pulmonary hypertension. Mol Genet Metab. 2018;125:351\u20138.","journal-title":"Mol Genet Metab"},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jpeds.2010.07.023","volume":"158","author":"KM McDowell","year":"2011","unstructured":"McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2011;158:319\u201325.","journal-title":"J Pediatr"},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1542\/peds.88.1.132","volume":"88","author":"CL Marcus","year":"1991","unstructured":"Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with Down syndrome. Pediatrics. 1991;88:132\u20139.","journal-title":"Pediatrics"},{"key":"251_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.5665\/sleep.5554","volume":"39","author":"M Maris","year":"2016","unstructured":"Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A. Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome. Sleep. 2016;39:699\u2013704.","journal-title":"Sleep"},{"key":"251_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/archpedi.157.7.655","volume":"157","author":"ME Dyken","year":"2003","unstructured":"Dyken ME, Lin-Dyken DC, Poulton S, Zimmerman MB, Sedars E. Prospective polysomnographic analysis of obstructive sleep apnea in Down syndrome. Arch Pediatr Adolesc Med. 2003;157:655\u201360.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/014107689809100612","volume":"91","author":"TI Ayeni","year":"1998","unstructured":"Ayeni TI, Roper HP. Pulmonary hypertension resulting from upper airways obstruction in Down\u2019s syndrome. J R Soc Med. 1998;91:321\u20132.","journal-title":"J R Soc Med"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0022-3476(81)80716-0","volume":"98","author":"GM Loughlin","year":"1981","unstructured":"Loughlin GM, Wynne JW, Victorica BE. Sleep apnea as a possible cause of pulmonary hypertension in Down syndrome. J Pediatr. 1981;98:435\u20137.","journal-title":"J Pediatr"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/ppul.24741","volume":"55","author":"M De Lausnay","year":"2020","unstructured":"De Lausnay M, Verhulst S, Boel L, Wojciechowski M, Boudewyns A, Van Hoorenbeeck K. The prevalence of lower airway anomalies in children with Down syndrome compared to controls. Pediatr Pulmonol. 2020;55:1259\u201363.","journal-title":"Pediatr Pulmonol"},{"key":"251_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ppul.10332","volume":"36","author":"P Bertrand","year":"2003","unstructured":"Bertrand P, Navarro H, Caussade S, Holmgren N, Sanchez I. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol. 2003;36:137\u201341.","journal-title":"Pediatr Pulmonol"},{"key":"251_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijporl.2015.11.027","volume":"81","author":"J Hamilton","year":"2016","unstructured":"Hamilton J, Yaneza MM, Clement WA, Kubba H. The prevalence of airway problems in children with Down\u2019s syndrome. Int J Pediatr Otorhinolaryngol. 2016;81:1\u20134.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"251_CR41","doi-asserted-by":"publisher","first-page":"E90","DOI":"10.1111\/chd.12088","volume":"9","author":"S Gowda","year":"2014","unstructured":"Gowda S, Bhat D, Feng Z, Chang CH, Ross RD. Pulmonary vein stenosis with Down syndrome: a rare and frequently fatal cause of pulmonary hypertension in infants and children. Congenit Heart Dis. 2014;9:E90\u20137.","journal-title":"Congenit Heart Dis"},{"key":"251_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1017\/S1047951114000419","volume":"25","author":"YK Ooi","year":"2015","unstructured":"Ooi YK, Sinha P, Gierdalski M, Harahsheh A. High-risk single ventricle palliation in children with Down syndrome: single institution experience. Cardiol Young. 2015;25:539\u201343.","journal-title":"Cardiol Young"},{"key":"251_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1213\/ANE.0000000000003924","volume":"129","author":"VG Nasr","year":"2019","unstructured":"Nasr VG, Callahan R, Wichner Z, Odegard KC, DiNardo JA. Intraluminal Pulmonary Vein Stenosis in Children: A \u201cNew\u201d Lesion. Anesth Analg. 2019;129:27\u201340.","journal-title":"Anesth Analg"},{"key":"251_CR44","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1136\/hrt.2008.161356","volume":"95","author":"AN Seale","year":"2009","unstructured":"Seale AN, Webber SA, Uemura H, Partridge J, Roughton M, Ho SY, et al. Pulmonary vein stenosis: the UK, Ireland and Sweden collaborative study. Heart. 2009;95:1944\u20139.","journal-title":"Heart"},{"key":"251_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21693\/1933-088X-18.1.37","volume":"18","author":"EO Jackson","year":"2019","unstructured":"Jackson EO, Davis A. PH Professional Network: Comprehensive evaluation and ongoing approach to children with Down syndrome who have pulmonary hypertension or are at risk of developing pulmonary hypertension. Adv Pulm Hypertens. 2019;18:37\u20139.","journal-title":"Adv Pulm Hypertens"},{"key":"251_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/peds.2011-1605","volume":"128","author":"MJ Bull","year":"2011","unstructured":"Bull MJ. Committee on G. Health supervision for children with Down syndrome. Pediatrics. 2011;128:393\u2013406.","journal-title":"Pediatrics"},{"key":"251_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MPH.0000000000000727","volume":"39","author":"KL Colvin","year":"2017","unstructured":"Colvin KL, Ivy DD, Yeager ME. Altered Peripheral Blood Myeloid Cell Subpopulations in Children With Down Syndrome and Pulmonary Hypertension. J Pediatr Hematol Oncol. 2017;39:158\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"251_CR48","doi-asserted-by":"crossref","unstructured":"Bush D, Wolter-Warmerdam K, Wagner BD, Galambos C, Ivy DD, Abman S, et al. EXPRESS: Angiogenic Profile Identifies Pulmonary Hypertension in Children with Down Syndrome. Pulmonary circulation. 2019:2045894019866549.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A4404"},{"key":"251_CR49","doi-asserted-by":"crossref","unstructured":"Griffiths M, Yang J, Vaidya D, Nies M, Brandal S, Ivy DD, et al. Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. J of Pediatr. 2021.","DOI":"10.1016\/j.jpeds.2021.10.017"},{"key":"251_CR50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00431-010-1378-1","volume":"170","author":"A Hawkins","year":"2011","unstructured":"Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM. Management of pulmonary hypertension in Down syndrome. Eur J Pediatr. 2011;170:915\u201321.","journal-title":"Eur J Pediatr"},{"key":"251_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/pan.12841","volume":"26","author":"AF Lewanda","year":"2016","unstructured":"Lewanda AF, Matisoff A, Revenis M, Harahsheh A, Futterman C, Nino G, et al. Preoperative evaluation and comprehensive risk assessment for children with Down syndrome. Paediatr Anaesth. 2016;26:356\u201362.","journal-title":"Paediatr Anaesth"},{"key":"251_CR52","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/hrt.2006.114660","volume":"94","author":"OH Balint","year":"2008","unstructured":"Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart. 2008;94:1189\u201393.","journal-title":"Heart"},{"key":"251_CR53","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00246-019-02080-9","volume":"40","author":"Y Iwaya","year":"2019","unstructured":"Iwaya Y, Muneuchi J, Inoue Y, Watanabe M, Okada S, Ochiai Y. Relationship between pulmonary arterial resistance and compliance in patients with Down syndrome. Pediatr Cardiol. 2019;40:841\u20137.","journal-title":"Pediatr Cardiol"},{"key":"251_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1542\/peds.2009-3245","volume":"126","author":"JC Fudge Jr","year":"2010","unstructured":"Fudge JC Jr, Li S, Jaggers J, O\u2019Brien SM, Peterson ED, Jacobs JP, et al. Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. Pediatrics. 2010;126:315\u201322.","journal-title":"Pediatrics"},{"key":"251_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijcard.2008.02.025","volume":"134","author":"MG Duffels","year":"2009","unstructured":"Duffels MG, Vis JC, van Loon RL, Berger RM, Hoendermis ES, van Dijk AP, et al. Down patients with Eisenmenger syndrome: is bosentan treatment an option? Int J Cardiol. 2009;134:378\u201383.","journal-title":"Int J Cardiol"},{"key":"251_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4137\/CMC.S10237","volume":"7","author":"G Serino","year":"2013","unstructured":"Serino G, Guazzi M, Micheletti A, Lombardi C, Danesi R, Negura D, et al. Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome. Clin Med Insights Cardiol. 2013;7:29\u201334.","journal-title":"Clin Med Insights Cardiol"},{"key":"251_CR57","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.amjcard.2009.01.021","volume":"103","author":"MG Duffels","year":"2009","unstructured":"Duffels MG, Vis JC, van Loon RL, Nieuwkerk PT, van Dijk AP, Hoendermis ES, et al. Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down\u2019s syndrome. Am J Cardiol. 2009;103:1309\u201315.","journal-title":"Am J Cardiol"},{"key":"251_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.hlc.2010.07.005","volume":"19","author":"FD Kermeen","year":"2010","unstructured":"Kermeen FD, Franks C, O\u2019Brien K, Seale H, Hall K, McNeil K, et al. Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21. Heart Lung Circ. 2010;19:595\u2013600.","journal-title":"Heart Lung Circ"},{"key":"251_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijcard.2011.07.009","volume":"164","author":"M D'Alto","year":"2013","unstructured":"D\u2019Alto M, Romeo E, Argiento P, D\u2019Andrea A, Sarubbi B, Correra A, et al. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down\u2019s syndrome. Int J Cardiol. 2013;164:323\u20136.","journal-title":"Int J Cardiol"},{"key":"251_CR60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12872-017-0569-3","volume":"17","author":"M Beghetti","year":"2017","unstructured":"Beghetti M, Rudzinski A, Zhang M. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension. BMC Cardiovasc Disord. 2017;17:177.","journal-title":"BMC Cardiovasc Disord"},{"key":"251_CR61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.chest.2018.11.030","volume":"155","author":"JR Klinger","year":"2019","unstructured":"Klinger JR, Elliott CG, Levine DJ, Bossone E, Duvall L, Fagan K, et al. Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 2019;155:565\u201386.","journal-title":"Chest"},{"key":"251_CR62","unstructured":"Bush D, Wolter-Warmerdam K, Wagner BD, Galambos C, Ivy DD, Abman S, et al. EXPRESS: Angiogenic Profile Identifies Pulmonary Hypertension in Children with Down Syndrome.0:2045894019866549."},{"key":"251_CR63","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","volume":"27","author":"M Gupta","year":"2016","unstructured":"Gupta M, Dhanasekaran AR, Gardiner KJ. Mouse models of Down syndrome: gene content and consequences. Mamm Genome. 2016;27:538\u201355.","journal-title":"Mamm Genome"},{"key":"251_CR64","doi-asserted-by":"crossref","unstructured":"Bush D, Galambos C, Dunbar Ivy D. Pulmonary hypertension in children with Down syndrome. Pediatric pulmonology. 2020.","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A4404"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-021-00251-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-021-00251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T22:02:08Z","timestamp":1700085728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-021-00251-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1007\/s40119-021-00251-5","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}